The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
iShares Biotechnology ETF IBB ETF Analysis
Morningstar’s Analysis IBB
Will IBB outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar